ArticleBMC oral health2026
Mechanical activation of Piezo1 promotes osteoclastogenesis in orthodontic tooth movement.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe initiation of bone remodeling by periodontal ligament cells (PDLCs) in response to force is pivotal for mediating orthodontic tooth movement (OTM). Piezo1 plays a pivotal role in the process of bone remodeling under mechanical stimulation. Our objective was to elucidate the role and mechanism of Piezo1 in force-treated PDLCs, and its influence on orthodontic bone remodeling.
methodsHuman PDLCs (hPDLCs) were isolated and treated with compressive force, along with either si-PIEZO1 or Yoda1. The expression of Piezo1 and the receptor activator of NF-kB ligand/osteoprotegerin (RANKL/OPG) ratio were assessed by quantitative real-time polymerase chain reaction (qPCR) and Western blots. Intracellular calcium ion influx was assessed with Fluo4-AM staining. The effect of force-treated hPDLCs on the osteoclastic differentiation of RAW264.7 cells was analyzed by tartrate-resistant acid phosphatase (TRAP) staining, qPCR and Western blots. After constructing the OTM model, rats were injected with GsMTx4 or Yoda1. OTM distance, osteoclast differentiation, and the expression of RANKL and phosphorylated-ERK1/2 was analyzed with micro-computed tomography, hematoxylin and eosin, TRAP, immunofluorescence and immunohistochemistry staining.
resultsCompressive force-activated Piezo1 in hPDLCs mediated RANKL/OPG upregulation via ERK1/2 phosphorylation, thereby facilitating osteoclast differentiation. Yoda1 amplified this effect, while knocking down Piezo1 suppresses it in force-treated hPDLCs. In vivo, Yoda1 enhanced OTM and osteoclastogenesis in rats, while GsMTx4 inhibited these processes. The expression of phosphorylated-ERK1/2 in periodontal ligaments on the compressive side was enhanced by Yoda1 and attenuated by GsMTx4.
conclusionsCompressive force-activated Piezo1 in PDLCs triggers the osteoclast differentiation and orthodontic bone remodeling via ERK1/2 signal pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.